Related references
Note: Only part of the references are listed.N-Heterocyclic Carbene Platinum Complexes: A Big Step Forward for Effective Antitumor Compounds
Stephane Bellemin-Laponnaz
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY (2020)
Synthesis, characterization, and antitumor activity of novel tumor-targeted platinum(IV) complexes
Yunshuang Zhong et al.
APPLIED ORGANOMETALLIC CHEMISTRY (2020)
A Photocaged, Water-Oxidizing, and Nucleolus-Targeted Pt(IV) Complex with a Distinct Anticancer Mechanism
Zhiqin Deng et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2020)
The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor Agents
Jiabei Zhou et al.
FRONTIERS IN PHARMACOLOGY (2020)
Photoactivatable Prodrug-Backboned Polymeric Nanoparticles for Efficient Light-Controlled Gene Delivery and Synergistic Treatment of Platinum-Resistant Ovarian Cancer
Qingfei Zhang et al.
NANO LETTERS (2020)
BODI-Pt, a Green-Light-Activatable and Carboplatin-Based Platinum(IV) Anticancer Prodrug with Enhanced Activation and Cytotoxicity
Houzong Yao et al.
INORGANIC CHEMISTRY (2020)
Photoactivated polyprodrug nanoparticles for effective light-controlled Pt(iv) and siRNA codelivery to achieve synergistic cancer therapy
Qingfei Zhang et al.
JOURNAL OF MATERIALS CHEMISTRY B (2020)
Biotinylated photoactive Pt(iv) anticancer complexes
Huayun Shi et al.
CHEMICAL COMMUNICATIONS (2020)
Glucose-conjugated platinum(IV) complexes as tumor-targeting agents: design, synthesis and biological evaluation
Haifeng Wang et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2019)
Self-assembled Lipid Nanoparticles for Ratiometric Codelivery of Cisplatin and siRNA Targeting XPF to Combat Drug Resistance in Lung Cancer
Cai Li et al.
CHEMISTRY-AN ASIAN JOURNAL (2019)
Self-Assembled Oxaliplatin(IV) Prodrug-Porphyrin Conjugate for Combinational Photodynamic Therapy and Chemotherapy
Wei Qi Lim et al.
ACS APPLIED MATERIALS & INTERFACES (2019)
Regulation of OCT2 transcriptional repression by histone acetylation in renal cell carcinoma
Qianying Zhu et al.
EPIGENETICS (2019)
Targeting Energy Metabolism by a Platinum(IV) Prodrug as an Alternative Pathway for Cancer Suppression
Suxing Jin et al.
INORGANIC CHEMISTRY (2019)
pH/redox dual-sensitive platinum (IV)-based micelles with greatly enhanced antitumor effect for combination chemotherapy
Le He et al.
JOURNAL OF COLLOID AND INTERFACE SCIENCE (2019)
Prodrugs in combination with nanocarriers as a strategy for promoting antitumoral efficiency
Ming-Hsien Lin et al.
FUTURE MEDICINAL CHEMISTRY (2019)
Enhancing Cytotoxicity of a Monofunctional Platinum Complex via a Dual-DNA-Damage Approach
Yan Guo et al.
INORGANIC CHEMISTRY (2019)
New Insights into Mechanisms of Cisplatin Resistance: From Tumor Cell to Microenvironment
Shang-Hung Chen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Cisplatin and oxaliplatin induce similar immunogenic changes in preclinical models of head and neck cancer
So-Jin Park et al.
ORAL ONCOLOGY (2019)
Inside Cover: Synergistic N-Heterocyclic Carbene/Palladium-Catalyzed Umpolung 1,4-Addition of Aryl Iodides to Enals (Angew. Chem. Int. Ed. 1/2020)
Wenjun Yang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2019)
Phorbiplatin, a Highly Potent Pt(IV) Antitumor Prodrug That Can Be Controllably Activated by Red Light
Zhigang Wang et al.
CHEM (2019)
An aminophosphonate ester ligand-containing platinum(II) complex induces potent immunogenic cell death in vitro and elicits effective anti-tumour immune responses in vivo
Ke-Bin Huang et al.
CHEMICAL COMMUNICATIONS (2019)
Photocytotoxic Pt(iv) complexes as prospective anticancer agents
Giovanni Canil et al.
DALTON TRANSACTIONS (2019)
Comparable effectiveness and immunomodulatory actions of oxaliplatin and cisplatin in electrochemotherapy of murine melanoma
Katja Ursic et al.
BIOELECTROCHEMISTRY (2018)
Targeted iron nanoparticles with platinum-(IV) prodrugs and anti-EZH2 siRNA show great synergy in combating drug resistance in vitro and in vivo
Chang Yu et al.
BIOMATERIALS (2018)
One-pot synthesis of pH-responsive charge-switchable PEGylated nanoscale coordination polymers for improved cancer therapy
Yu Yang et al.
BIOMATERIALS (2018)
KRAS mutations in cell- free DNA from preoperative and postoperative sera as a pancreatic cancer marker: a retrospective study
Yutaka Nakano et al.
BRITISH JOURNAL OF CANCER (2018)
Pt(IV)-based nanoscale coordination polymers: Antitumor activity, cellular uptake and interactions with nuclear DNA
N. N. Adarsh et al.
CHEMICAL ENGINEERING JOURNAL (2018)
Anticancer metal-N-heterocyclic carbene complexes of gold, platinum and palladium
Taotao Zou et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2018)
Nanoparticles of metal-organic cages designed to encapsulate platinum-based anticancer agents
Zhizhou Yue et al.
DALTON TRANSACTIONS (2018)
Synthesis, characterization and biological activity of new cyclometallated platinum(IV) complexes containing a para-tolyl ligand
Monica Sole et al.
DALTON TRANSACTIONS (2018)
Pt(IV) complexes conjugating with chalcone analogue as inhibitors of microtubule polymerization exhibited selective inhibition in human cancer cells
Xiaochao Huang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Intracellular glutathione-depleting polymeric micelles for cisplatin prodrug delivery to overcome cisplatin resistance of cancers
Yu Han et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Pancreatic tumor microenvironment confers highly malignant properties on pancreatic cancer cells
Kei Takahashi et al.
ONCOGENE (2018)
Recent progress in polymer-based platinum drug delivery systems
Haihua Xiao et al.
PROGRESS IN POLYMER SCIENCE (2018)
Oxygen and Pt(ll) self-generating conjugate for synergistic photo-chemo therapy of hypoxic tumor
Shuting Xu et al.
NATURE COMMUNICATIONS (2018)
1,8-Naphthalimide based DNA intercalators and anticancer agents. A systematic review from 2007 to 2017
Mateusz D. Tomczyk et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Impact of Mitochondrion-Targeting Group on the Reactivity and Cytostatic Pathway of Platinum(IV) Complexes
Suxing Jin et al.
INORGANIC CHEMISTRY (2018)
Mechanism of hydrolysis of a platinum(IV) complex discovered by atomic telemetry
Joanna Czapla-Masztafiak et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2018)
A Drug of Such Damned Nature. Challenges and Opportunities in Translational Platinum Drug Research (vol 60, pg 4517, 2017)
Dorian M. Cheff et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Photoactivatable Cell-Selective Dinuclear trans-Diazidoplatinum(IV) Anticancer Prodrugs
Huayun Shi et al.
INORGANIC CHEMISTRY (2018)
Platinum(IV)-nitroxyl complexes as possible candidates to circumvent cisplatin resistance in RT112 bladder cancer cells
Maria Cetraz et al.
ARCHIVES OF TOXICOLOGY (2017)
Enhancing the Cytotoxic Activity of Anticancer PtIV Complexes by Introduction of Lonidamine as an Axial Ligand
Yulia N. Nosova et al.
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY (2017)
Platinum(IV) Prodrugs - A Step Closer to Ehrlich's Vision?
Reece G. Kenny et al.
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY (2017)
Conjugation of platinum(IV) complexes with chlorambucil to overcome cisplatin resistance via a joint action mode toward DNA
Xiaodong Qin et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Mono-functionalized glycosylated platinum(IV) complexes possessed both pH and redox dual-responsive properties: Exhibited enhanced safety and preferentially accumulated in cancer cells in vitro and in vivo
Jing Ma et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Polymeric micelles for targeted tumor therapy of platinum anticancer drugs
Yuki Mochida et al.
EXPERT OPINION ON DRUG DELIVERY (2017)
Enhanced Cytotoxicity and Reactivity of a Novel Platinum(IV) Family with DNA-Targeting Naphthalimide Ligands
Francisco Navas et al.
INORGANIC CHEMISTRY (2017)
PGRMC1-dependent autophagy by hyperoside induces apoptosis and sensitizes ovarian cancer cells to cisplatin treatment
Xiaofei Zhu et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
Resveratrol-induced autophagy and apoptosis in cisplatin-resistant human oral cancer CAR cells: A key role of AMPK and Akt/mTOR signaling
Chao-Hsiang Chang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
Interactions of cisplatin and the copper transporter CTR1 in human colon cancer cells
Mia C. Akerfeldt et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2017)
Biotinylated platinum(IV) complexes designed to target cancer cells
Jian Zhao et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2017)
Supramolecular Photoactivatable Anticancer Hydrogels
V. Venkatesh et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2017)
Comparative studies of oxaliplatin-based platinum(IV) complexes in different in vitro and in vivo tumor models
Simone Goeschl et al.
METALLOMICS (2017)
Enhanced Cisplatin Chemotherapy by Iron Oxide Nanocarrier-Mediated Generation of Highly Toxic Reactive Oxygen Species
Ping'an Ma et al.
NANO LETTERS (2017)
Bundling potent natural toxin cantharidin within platinum (IV) prodrugs for liposome drug delivery and effective malignant neuroblastoma treatment
Xi Yang et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2017)
Nanostructures for NIR light-controlled therapies
Yanmei Yang et al.
NANOSCALE (2017)
A subset of platinum-containing chemotherapeutic agents kills cells by inducing ribosome biogenesis stress
Peter M. Bruno et al.
NATURE MEDICINE (2017)
Nanoparticles for modulating tumor microenvironment to improve drug delivery and tumor therapy
Shu Yang et al.
PHARMACOLOGICAL RESEARCH (2017)
A spectroscopic investigation into the binding of novel platinum(IV) and platium(II) anticancer drugs with DNA
Rukshani Haputhanthri et al.
VIBRATIONAL SPECTROSCOPY (2017)
Liposome-targeted delivery for highly potent drugs
Hassan Bardania et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2017)
Phospholipid-mimic oxaliplatin prodrug liposome for treatment of the metastatic triple negative breast cancer
Bing Feng et al.
BIOMATERIALS SCIENCE (2017)
Pt(IV) prodrug-backboned micelle and DCA loaded nanofibers for enhanced local cancer treatment
Zhiyun Zhang et al.
JOURNAL OF MATERIALS CHEMISTRY B (2017)
Synthesis, characterization and biological activity of new cyclometallated platinum(IV) iodido complexes
Emma Bauer et al.
DALTON TRANSACTIONS (2017)
Supramolecular chemotherapy based on host-guest molecular recognition: a novel strategy in the battle against cancer with a bright future
Jiong Zhou et al.
CHEMICAL SOCIETY REVIEWS (2017)
Overcoming resistance to cisplatin by inhibition of glutathione S-transferases (GSTs) with ethacraplatin micelles in vitro and in vivo
Shuyi Li et al.
BIOMATERIALS (2017)
A Quadruple-Action Platinum(IV) Prodrug with Anticancer Activity Against KRAS Mutated Cancer Cell Lines
Emanuele Petruzzella et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)
Chemotherapy and tumor microenvironment of pancreatic cancer
Qiaofei Liu et al.
CANCER CELL INTERNATIONAL (2017)
Reversal of cisplatin resistance in human gastric cancer cells by a wogonin-conjugated Pt(IV) prodrug via attenuating Casein Kinase 2-mediated Nuclear Factor-κB pathways
Feihong Chen et al.
BIOCHEMICAL PHARMACOLOGY (2017)
Charge convertibility and near infrared photon co-enhanced cisplatin chemotherapy based on upconversion nanoplatform
Jiating Xu et al.
BIOMATERIALS (2017)
Programmed Multiresponsive Vesicles for Enhanced Tumor Penetration and Combination Therapy of Triple-Negative Breast Cancer
Fangyuan Zhou et al.
ADVANCED FUNCTIONAL MATERIALS (2017)
Novel platinum(IV) complexes conjugated with a wogonin derivative as multi-targeted anticancer agents
Xiaodong Qin et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
Novel hypoxia-targeting Pt(IV) prodrugs
Zichen Xu et al.
CHEMICAL COMMUNICATIONS (2017)
Finely Tuned Asymmetric Platinum(IV) Anticancer Complexes: Structure-Activity Relationship and Application as Orally Available Prodrugs
Siew Qi Yap et al.
CHEMMEDCHEM (2017)
A CK2-targeted Pt(IV) prodrug to disrupt DNA damage response
Feihong Chen et al.
CANCER LETTERS (2017)
Co-Delivery of Cisplatin Prodrug and Chlorin e6 by Mesoporous Silica Nanoparticles for Chemo-Photodynamic Combination Therapy to Combat Drug Resistance
Wei Zhang et al.
ACS APPLIED MATERIALS & INTERFACES (2016)
Co-delivery of drugs and plasmid DNA for cancer therapy
Pei Yun Teo et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
A Platinum(IV) Anticancer Prodrug Targeting Nucleotide Excision Repair To Overcome Cisplatin Resistance
Zhigang Wang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Combretastatin A-4 Analogue: A Dual-Targeting and Tubulin Inhibitor Containing Antitumor Pt(IV) Moiety with a Unique Mode of Action
Xiaochao Huang et al.
BIOCONJUGATE CHEMISTRY (2016)
Linking of Antitumor trans NHC-Pt(II) Complexes to G-Quadruplex DNA Ligand for Telomeric Targeting
Jean-Francois Betzer et al.
BIOCONJUGATE CHEMISTRY (2016)
Overcoming tumor resistance to cisplatin by cationic lipid-assisted prodrug nanoparticles
Zhi-Ting Cao et al.
BIOMATERIALS (2016)
On the stability and biological behavior of cyclometallated Pt(IV) complexes with halido and aryl ligands in the axial positions
Anna Escola et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Platinum (IV)-fatty acid conjugates overcome inherently and acquired Cisplatin resistant cancer cell lines: an in-vitro study
Einav Ratzon et al.
BMC CANCER (2016)
Platinum-based drugs: past, present and future
Shahana Dilruba et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
Timothy C. Johnstone et al.
CHEMICAL REVIEWS (2016)
Desymmetrization of an Octahedral Coordination Complex Inside a Self-Assembled Exoskeleton
Mark D. Johnstone et al.
CHEMISTRY-A EUROPEAN JOURNAL (2016)
New trends in platinum and palladium complexes as antineoplastic agents
Mirco Fanelli et al.
COORDINATION CHEMISTRY REVIEWS (2016)
More of a misunderstanding than a real mismatch? Platinum and its affinity for aqua, hydroxido, and oxido ligands
Bernhard Lippert et al.
COORDINATION CHEMISTRY REVIEWS (2016)
Antiproliferative activity of a series of cisplatin-based Pt(IV)-acetylamido/carboxylato prodrugs
Mauro Ravera et al.
DALTON TRANSACTIONS (2016)
Anticancer activity of a chelating nitrogen mustard bearing tetrachloridoplatinum(IV) complex: better stability yet equipotent to the Pt(II) analogue
Subhendu Karmakar et al.
DALTON TRANSACTIONS (2016)
Encapsulation of lipophilic kiteplatin Pt(IV) prodrugs in PLGA-PEG micelles
Nicola Margiotta et al.
DALTON TRANSACTIONS (2016)
Platinum(IV) N-heterocyclic carbene complexes: their synthesis, characterisation and cytotoxic activity
M. Bouche et al.
DALTON TRANSACTIONS (2016)
Reduction of ormaplatin and cis-diamminetetrachloroplatinum(IV) by ascorbic acid and dominant thiols in human plasma: kinetic and mechanistic analyses
Jingran Dong et al.
DALTON TRANSACTIONS (2016)
Mechanisms of cisplatin resistance and targeting of cancer stem cells: Adding glycosylation to the equation
Jose Alexandre Ferreira et al.
DRUG RESISTANCE UPDATES (2016)
Comprehensive Vibrational Spectroscopic Investigation of trans,trans,trans-[Pt(N3)2(OH)2(py)2], a Pt(IV) Diazido Anticancer Prodrug Candidate
Robbin R. Vemooij et al.
INORGANIC CHEMISTRY (2016)
Mitochondria and Mitochondrial ROS in Cancer: Novel Targets for Anticancer Therapy
Yuhui Yang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2016)
Potentiation of mitochondrial dysfunction in tumor cells by conjugates of metabolic modulator dichloroacetate with a Pt(IV) derivative of oxaliplatin
Juraj Zajac et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2016)
Copper transporters and chaperones CTR1, CTR2, ATOX1, and CCS as determinants of cisplatin sensitivity
Kristin M. Bompiani et al.
METALLOMICS (2016)
Photoactivation of Diiodido-Pt(IV) Complexes Coupled to Upconverting Nanoparticles
Stefanie Perfahl et al.
MOLECULAR PHARMACEUTICS (2016)
Glutathione boosting the cytotoxicity of a magnetic platinum(IV) nano-prodrug in tumor cells
Zhenzhu Zhu et al.
CHEMICAL SCIENCE (2016)
Molecular mechanisms of cisplatin resistance in cervical cancer
Haiyan Zhu et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2016)
Simultaneously Photo-Cleavable and Activatable Prodrug-Backboned Block Copolymer Micelles for Precise Anticancer Drug Delivery
Dongfang Zhou et al.
ADVANCED HEALTHCARE MATERIALS (2016)
New insights into the molecular and epigenetic effects of antitumor Pt(IV)-valproic acid conjugates in human ovarian cancer cells
Vojtech Novohradsky et al.
BIOCHEMICAL PHARMACOLOGY (2015)
Co-delivery of platinum drug and siNotch1 with micelleplex for enhanced hepatocellular carcinoma therapy
Song Shen et al.
BIOMATERIALS (2015)
Self-assembled nanoscale coordination polymers carrying siRNAs and cisplatin for effective treatment of resistant ovarian cancer
Chunbai He et al.
BIOMATERIALS (2015)
Autophagy contributes to the enrichment and survival of colorectal cancer stem cells under oxaliplatin treatment
Hao-Zheng Yang et al.
CANCER LETTERS (2015)
Efficient co-delivery of a Pt(IV) prodrug and a p53 activator to enhance the anticancer activity of cisplatin
Rong Ma et al.
CHEMICAL COMMUNICATIONS (2015)
Delivering a photosensitive transplatin prodrug to overcome cisplatin drug resistance
Haiqin Song et al.
CHEMICAL COMMUNICATIONS (2015)
Near infrared activation of an anticancer Pt-IV complex by Tm-doped upconversion nanoparticles
Emmanuel Ruggiero et al.
CHEMICAL COMMUNICATIONS (2015)
An integrin-targeted photoactivatable Pt(IV) complex as a selective anticancer pro-drug: synthesis and photoactivation studies
Albert Gandioso et al.
CHEMICAL COMMUNICATIONS (2015)
Recent Developments in the Preparation and Chemistry of Metallacycles and Metallacages via Coordination
Timothy R. Cook et al.
CHEMICAL REVIEWS (2015)
A Photoactivatable Platinum(IV) Anticancer Complex Conjugated to the RNA Ligand Guanidinoneomycin
Evyenia Shaili et al.
CHEMISTRY-A EUROPEAN JOURNAL (2015)
Mono- and di-bromo platinum(IV) prodrugs via oxidative bromination: synthesis, characterization, and cytotoxicity
Zoufeng Xu et al.
DALTON TRANSACTIONS (2015)
Integrin-targeted delivery into cancer cells of a Pt(IV) pro-drug through conjugation to RGD-containing peptides
Anna Massaguer et al.
DALTON TRANSACTIONS (2015)
Targeting autophagy to overcome drug resistance in cancer therapy
Ankit Kumar et al.
FUTURE MEDICINAL CHEMISTRY (2015)
The anti-malarial chloroquine suppresses proliferation and overcomes cisplatin resistance of endometrial cancer cells via autophagy inhibition
Tomohiko Fukuda et al.
GYNECOLOGIC ONCOLOGY (2015)
Autophagic flux promotes cisplatin resistance in human ovarian carcinoma cells through ATP-mediated lysosomal function
Liwei Ma et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Improving drug delivery to solid tumors: Priming the tumor microenvironment
Iftikhar Ali Khawar et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Functional fluorescent nonporous silica nanoparticles as carriers for Pt(IV) anticancer prodrugs
Mauro Ravera et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2015)
A Pt(IV) Pro-drug Preferentially Targets Indoleamine-2,3-dioxygenase, Providing Enhanced Ovarian Cancer Immuno-Chemotherapy
Samuel G. Awuah et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2015)
Inorganic nanocarriers for platinum drug delivery
Ping'an Ma et al.
MATERIALS TODAY (2015)
Recent Advances in Platinum (IV) Complex-Based Delivery Systems to Improve Platinum (II) Anticancer Therapy
Xiaopeng Han et al.
MEDICINAL RESEARCH REVIEWS (2015)
Diameter-dependent release of a cisplatin pro-drug from small and large functionalized carbon nanotubes
Laura Muzi et al.
NANOSCALE (2015)
Encapsulation of Pt(IV) prodrugs within a Pt(II) cage for drug delivery
Yao-Rong Zheng et al.
CHEMICAL SCIENCE (2015)
Overcoming tumor resistance to cisplatin through micelle-mediated combination chemotherapy
Dongfang Zhou et al.
BIOMATERIALS SCIENCE (2015)
On the Stability of PtIV Pro-Drugs with Haloacetato Ligands in the Axial Positions
Ezequiel Wexselblatt et al.
CHEMISTRY-A EUROPEAN JOURNAL (2015)
Conjugation of Cisplatin Analogues and Cyclooxygenase Inhibitors to Overcome Cisplatin Resistance
Wilma Neumann et al.
CHEMMEDCHEM (2015)
p53 protein aggregation promotes platinum resistance in ovarian cancer
Y. Yang-Hartwich et al.
ONCOGENE (2015)
Oligonucleotides-Assembled Au Nanorod-Assisted Cancer Photothermal Ablation and Combination Chemotherapy with Targeted Dual-Drug Delivery of Doxorubicin and Cisplatin Prodrug
Vijayakumar Shanmugam et al.
ACS APPLIED MATERIALS & INTERFACES (2014)
Neuropilin-1-Targeted Gold Nanoparticles Enhance Therapeutic Efficacy of Platinum(IV) Drug for Prostate Cancer Treatment
Anil Kumar et al.
ACS NANO (2014)
Immuno-Chemotherapeutic Platinum(IV) Prodrugs of Cisplatin as Multimodal Anticancer Agents
Daniel Yuan Qiang Wong et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
Iron and Reactive Oxygen Species: Friends or Foes of Cancer Cells?
Laura M. Bystrom et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
Bag-1L is a Stress-withstand Molecule Prevents the Downregulation of Mcl-1 and c-Raf Under Control of Heat Shock Proteins in Cisplatin Treated HeLa Cervix Cancer Cells
Pelin Ozfiliz et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Induction of autophagy counteracts the anticancer effect of cisplatin in human esophageal cancer cells with acquired drug resistance
Le Yu et al.
CANCER LETTERS (2014)
The role of DNA repair pathways in cisplatin resistant lung cancer
Shane O'Grady et al.
CANCER TREATMENT REVIEWS (2014)
Conjugation of vitamin E analog α-TOS to Pt(IV) complexes for dual-targeting anticancer therapy
Kogularamanan Suntharalingam et al.
CHEMICAL COMMUNICATIONS (2014)
The ligation of aspirin to cisplatin demonstrates significant synergistic effects on tumor cells
Qinqin Cheng et al.
CHEMICAL COMMUNICATIONS (2014)
A targeted theranostic platinum(IV) prodrug containing a luminogen with aggregation-induced emission (AIE) characteristics for in situ monitoring of drug activation
Youyong Yuan et al.
CHEMICAL COMMUNICATIONS (2014)
Synthetic Methods for the Preparation of Platinum Anticancer Complexes
Justin J. Wilson et al.
CHEMICAL REVIEWS (2014)
Cover Picture: Photoinduced Reduction of PtIVwithin an Anti-Proliferative PtIV-Texaphyrin Conjugate (Chem. Eur. J. 29/2014)
Grégory Thiabaud et al.
CHEMISTRY-A EUROPEAN JOURNAL (2014)
Conjugates of Cisplatin and Cyclooxygenase Inhibitors as Potent Antitumor Agents Overcoming Cisplatin Resistance
Wilma Neumann et al.
CHEMMEDCHEM (2014)
Pros and cons of bifunctional platinum(IV) antitumor prodrugs: two are (not always) better than one
Elisabetta Gabano et al.
DALTON TRANSACTIONS (2014)
DNA Condensing Effects and Sequence Selectivity of DNA Binding of Antitumor Noncovalent Polynuclear Platinum Complexes
Jaroslav Malina et al.
INORGANIC CHEMISTRY (2014)
Progress of drug-loaded polymeric micelles into clinical studies
Horacio Cabral et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Antitumor platinum(IV) derivatives of oxaliplatin with axial valproato ligands
Vojtech Novohradsky et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2014)
Cytotoxicity of cyclometalated platinum complexes based on tridentate NCN and CNN-coordinating ligands: Remarkable coordination dependence
Dileep A. K. Vezzu et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2014)
Nanoscale Metal-Organic Frameworks for the Co-Delivery of Cisplatin and Pooled siRNAs to Enhance Therapeutic Efficacy in Drug-Resistant Ovarian Cancer Cells
Chunbai He et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
Pt(IV) Prodrugs Designed to Bind Non-Covalently to Human Serum Albumin for Drug Delivery
Yao-Rong Zheng et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
Recent development of silica nanoparticles as delivery vectors for cancer imaging and therapy
Xu Wu et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2014)
An overview of N-heterocyclic carbenes
Matthew N. Hopkinson et al.
NATURE (2014)
Synergistic Effect of Pyrrolidine Dithiocarbamate and Cisplatin in Human Cervical Carcinoma
Xiaodong Zheng et al.
REPRODUCTIVE SCIENCES (2014)
Ratiometric delivery of cisplatin and doxorubicin using tumour-targeting carbon-nanotubes entrapping platinum(IV) prodrugs
Chee Fei Chin et al.
CHEMICAL SCIENCE (2014)
Novel combination of mitochondrial division inhibitor 1 (mdivi-1) and platinum agents produces synergistic pro-apoptotic effect in drug resistant tumor cells
Wei Qian et al.
ONCOTARGET (2014)
Enzyme-triggered supramolecular self-assembly of platinum prodrug with enhanced tumor-selective accumulation and reduced systemic toxicity
Huan Liu et al.
JOURNAL OF MATERIALS CHEMISTRY B (2014)
Reversing platinum resistance in high-grade serous ovarian carcinoma: targeting BRCA and the homologous recombination system
W. Ruprecht Wiedemeyer et al.
FRONTIERS IN ONCOLOGY (2014)
Challenges for Metals in Medicine: How Nanotechnology May Help To Shape the Future
Nicolas P. E. Barry et al.
ACS NANO (2013)
Carbon nanotubes for delivery of small molecule drugs
Bin Sheng Wong et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
Platinum Compounds: A Hope for Future Cancer Chemotherapy
Imran Ali et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2013)
Synthesis and Characterization of Pt(IV) Fluorescein Conjugates to Investigate Pt(IV) Intracellular Transformations
Ying Song et al.
BIOCONJUGATE CHEMISTRY (2013)
The Effect of Ligand Lipophilicity on the Nanoparticle Encapsulation of Pt(IV) Prodrugs
Timothy C. Johnstone et al.
INORGANIC CHEMISTRY (2013)
Recent Developments in Texaphyrin Chemistry and Drug Discovery
Christian Preihs et al.
INORGANIC CHEMISTRY (2013)
Cyclodextrin Capped Gold Nanoparticles as a Delivery Vehicle for a Prodrug of Cisplatin
Yi Shi et al.
INORGANIC CHEMISTRY (2013)
Clinical and pharmacokinetic evaluation of satraplatin
Gury Doshi et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2012)
Systematic differences in electrochemical reduction of the structurally characterized anti-cancer platinum(IV) complexes [Pt{((p-HC6F4)NCH2)2}-(pyridine)2Cl2], [Pt{((p-HC6F4)NCH2)2}(pyridine)2(OH)2], and [Pt{((p-HC6F4)NCH2)2}(pyridine)2(OH)Cl]
Si-Xuan Guo et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2012)
What do we know about the reduction of Pt(IV) pro-drugs?
Ezequiel Wexselblatt et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2012)
Mitaplatin Increases Sensitivity of Tumor Cells to Cisplatin by Inducing Mitochondrial Dysfunction
Xue Xue et al.
MOLECULAR PHARMACEUTICS (2012)
Molecular mechanisms of cisplatin resistance
L. Galluzzi et al.
ONCOGENE (2012)
A texaphyrin-oxaliplatin conjugate that overcomes both pharmacologic and molecular mechanisms of cisplatin resistance in cancer cells
Jonathan F. Arambula et al.
MEDCHEMCOMM (2012)
Activating Platinum Anticancer Complexes with Visible Light
Susan J. Berners-Price
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2011)
A Phase I clinical study of cisplatin-incorporated polymeric micelles (NC-6004) in patients with solid tumours
R. Plummer et al.
BRITISH JOURNAL OF CANCER (2011)
Role of Endonucleases XPF and XPG in Nucleotide Excision Repair of Platinated DNA and Cisplatin/Oxaliplatin Cytotoxicity
Nora Graf et al.
CHEMBIOCHEM (2011)
Studies of Glutathione Transferase P1-1 Bound to a Platinum(IV)-Based Anticancer Compound Reveal the Molecular Basis of Its Activation
Lorien J. Parker et al.
CHEMISTRY-A EUROPEAN JOURNAL (2011)
Drug transporters of platinum-based anticancer agents and their clinical significance
Herman Burger et al.
DRUG RESISTANCE UPDATES (2011)
Anticancer drugs that target metabolism: is dichloroacetate the new paradigm?
Ioanna Papandreou et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Copper Transporter 2 Regulates Endocytosis and Controls Tumor Growth and Sensitivity to Cisplatin In Vivo
Brian G. Blair et al.
MOLECULAR PHARMACOLOGY (2011)
Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress
I. Martins et al.
ONCOGENE (2011)
Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects
Ana-Maria Florea et al.
Cancers (2011)
Targeting hypoxia in cancer therapy
William R. Wilson et al.
NATURE REVIEWS CANCER (2011)
Photocytotoxic trans-Diam(m)ine Platinum(IV) Diazido Complexes More Potent than Their cis Isomers
Nicola J. Farrer et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2010)
The status of platinum anticancer drugs in the clinic and in clinical trials
Nial J. Wheate et al.
DALTON TRANSACTIONS (2010)
To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery
Fabienne Danhier et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Enzymatic Processing of Platinated RNAs
Erich G. Chapman et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
The new platinum(IV) derivative LA-12 shows stronger inhibitory effect on Hsp90 function compared to cisplatin
Veronika Kvardova et al.
MOLECULAR CANCER (2010)
Immunogenic death of colon cancer cells treated with oxaliplatin
A. Tesniere et al.
ONCOGENE (2010)
Integrins in cancer: biological implications and therapeutic opportunities
Jay S. Desgrosellier et al.
NATURE REVIEWS CANCER (2010)
ProLindac™ (AP5346): A review of the development of an HPMA DACH platinum Polymer Therapeutic
David P. Nowotnik et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Electro-Fenton Process and Related Electrochemical Technologies Based on Fenton's Reaction Chemistry
Enric Brillas et al.
CHEMICAL REVIEWS (2009)
Copper Transporter 2 Regulates the Cellular Accumulation and Cytotoxicity of Cisplatin and Carboplatin
Brian G. Blair et al.
CLINICAL CANCER RESEARCH (2009)
Clinical overview on Lipoplatin™: a successful liposomal formulation of cisplatin
Teni Boulikas
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
The DNA-damage response in human biology and disease
Stephen P. Jackson et al.
NATURE (2009)
Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate
Shanta Dhar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The role of cellular accumulation in determining sensitivity to platinum-based chemotherapy
Matthew D. Hall et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2008)
Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer
E. D. Michelakis et al.
BRITISH JOURNAL OF CANCER (2008)
Current status and future prospects for satraplatin, an oral platinum analogue
Hak Choy et al.
CLINICAL CANCER RESEARCH (2008)
Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): Cyclooxygenase (COX) inhibition and beyond
P. N. Praveen Rao et al.
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES (2008)
Targeted single-wall carbon nanotube-mediated Pt(IV) prodrug delivery using folate as a homing device
Shanta Dhar et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
Metal-Ligand Exchange Kinetics in Platinum and Ruthenium Complexes SIGNIFICANCE FOR EFFECTIVENESS AS ANTICANCER DRUGS
Jan Reedijk
PLATINUM METALS REVIEW (2008)
Apoptosis by cisplatin requires p53 mediated p38α MAPK activation through ROS generation
Paloma Bragado et al.
APOPTOSIS (2007)
Basis for design and development of Platinum(IV) anticancer complexes
Matthew D. Hall et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Soluble single-walled carbon nanotubes as longboat delivery systems for Platinum(IV) anticancer drug design
Rodney P. Feazell et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2007)
Broadening the clinical use of platinum drug-based chemotherapy with new analogues: satraplatin and picoplatin
Lloyd Kelland
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2007)
Activation of mitogen-activated protein kinases by cisplatin and their role in cisplatin-resistance
Anamaria Brozovic et al.
CANCER LETTERS (2007)
Nuclear metallothionein expression correlates with cisplatin resistance of ovarian cancer cells and poor clinical outcome
Pawel Surowiak et al.
VIRCHOWS ARCHIV (2007)
Molecular mechanisms of resistance and toxicity associated with platinating agents
Cara A. Rabik et al.
CANCER TREATMENT REVIEWS (2007)
Photoactivatable Platinum Complexes
Patrick J. Bednarski et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2007)
Valproic acid enhances tubulin acetylation and apoptotic activity of paclitaxel on anaplastic thyroid cancer cell lines
Maria G. Catalano et al.
ENDOCRINE-RELATED CANCER (2007)
Targeting tumor-associated carbonic anhydrase IX in cancer therapy
Anne Thiry et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2006)
Organic cation transporters are determinants of oxaliplatin cytotoxicity
Shuzhong Zhang et al.
CANCER RESEARCH (2006)
Satraplatin: an orally available platinum analog for the treatment of cancer
Hak Choy
EXPERT REVIEW OF ANTICANCER THERAPY (2006)
Trafficking and localization of platinum complexes in cisplatin-resistant cell lines monitored by fluorescence-labeled platinum
XJ Liang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2005)
Rational design of platinum(IV) compounds to overcome glutathione-S-transferase mediated drug resistance
WH Ang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2005)
Recognition and processing of cisplatin- and oxaliplatin-DNA adducts
SG Chaney et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2005)
Why do cancers have high aerobic glycolysis?
RA Gatenby et al.
NATURE REVIEWS CANCER (2004)
Mismatch repair and response to DNA-damaging antitumour therapies
M Bignami et al.
EUROPEAN JOURNAL OF CANCER (2003)
Harnessing the response to tissue hypoxia -: HIF-1α and therapeutic angiogenesis
KA Vincent et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2002)
Platinum(IV) antitumour compounds: their bioinorganic chemistry
MD Hall et al.
COORDINATION CHEMISTRY REVIEWS (2002)
Distinct functions of COX-1 and COX-2
I Morita
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2002)
Mechanisms of resistance to cisplatin
M Kartalou et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2001)
Pharmacokinetic and pharmacodynamic analysis of bis-acetato-ammine-dichloro-cyclohexylamine-platinum (JM216) administered once a day for five consecutive days: A phase I study
T Kurata et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2000)
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
H Maeda et al.
JOURNAL OF CONTROLLED RELEASE (2000)
Share Paper
